Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;36(11):974-980.
doi: 10.1177/08830738211019284.

Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement

Affiliations

Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement

Dylan Brock et al. J Child Neurol. 2021 Oct.

Abstract

Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder is a rare neurodevelopmental disorder characterized by infantile-onset refractory epilepsy, profound developmental delays, and cerebral visual impairment. Although there is evidence that the presence of cerebral visual impairment in CDKL5 deficiency disorder is common, the potential impact of cerebral visual impairment severity on developmental attainment has not been explored directly. Focusing on a cohort of 46 children with CDKL5 deficiency disorder, examination features indicative of cerebral visual impairment were quantified and compared to developmental achievement. The derived cerebral visual impairment severity score was inversely correlated with developmental attainment, bolstering the supposition that cerebral visual impairment severity may provide a useful early biomarker of disease severity and prognosis. This study demonstrates the utility of a cerebral visual impairment score to better capture the range of cerebral visual impairment severity in the CDKL5 deficiency disorder population and further elucidates the interaction between cerebral visual impairment and developmental outcomes.

Keywords: CDKL5 deficicency disorder; Cerebral vision impairment; developmental and epileptic encephalopathy; developmental outcome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
CVI Severity Score: List of CVI Variables and their Corresponding ‘Points.’ The Variables, when Present on Exam, are Summed According to their Value. Minimum Score Possible = 0; Maximum Points Possible = 7.
Figure 2.
Figure 2.
7-Point Development Scale: Variables included in the 7-Point Developmental Scale, Subdivided into Three Domains (i.e., Gross Motor, Hand Function, Expressive Communication). The Variables within each Domain are Considered Ordinal, such that the Presence of more Advanced Milestones Assume Preceding Milestones if not otherwise Indicated on History. Minimum Score Possible = 0; Maximum Points Possible = 7.
Figure 3.
Figure 3.
16-Point Development Scale: Variables Included in the Expanded 16-point Developmental Scale, Subdivided into four Domains (i.e., Gross Motor, Hand Function, Expressive Communication, Social/Cognitive). Expressive Communication was Further Divided into Verbal and Nonverbal Communication. Each Domain has a Maximum of four Possible Points. Minimum Score Possible = 0; Maximum Points Possible = 16.
Figure 4.
Figure 4.
Scatterplot of CVI scores vs developmental scores. Adjusted R-Square and prediction line based on multiple linear regression model. A jitter option was used to see overlapping points.

References

    1. Weaving LS, Christodoulou J, Williamson SL, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004;75(6):1079–1093. - PMC - PubMed
    1. Bahi-Buisson N, Bienvenu T. CDKL5-Related Disorders: From Clinical Description to Molecular Genetics. Mol Syndromol. 2012;2(3–5):137–152. - PMC - PubMed
    1. Bahi-Buisson N, Villeneuve N, Caietta E, et al. Recurrent mutations in the CDKL5 gene: genotype-phenotype relationships. Am J Med Genet A. 2012;158A(7):1612–1619. - PubMed
    1. Moseley BD, Dhamija R, Wirrell EC, Nickels KC. Historic, clinical, and prognostic features of epileptic encephalopathies caused by CDKL5 mutations. Pediatr Neurol. 2012;46(2):101–105. - PubMed
    1. Fuchs C, Trazzi S, Torricella R, et al. Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3beta signaling. Neurobiol Dis. 2014;70:53–68. - PMC - PubMed

Publication types

Supplementary concepts